Drug Profile
BD 1054
Latest Information Update: 14 Mar 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Neuroprotectants; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 14 Mar 2001 No-Development-Reported for Alzheimer's disease in Russia (Unknown route)
- 12 Dec 1997 Preclinical development for Alzheimer's disease in Russia (Unknown route)
- 12 Mar 1996 New profile